A new NAMS study officially names perimenopause uncertainty as a clinically distinct and widespread experience — and explains why so many women feel dismissed or confused before they ever get a diagnosis. This episode also covers a promising randomized trial on compassionate mind training for menopause-related mood and anxiety, and takes a hard look at what "shows promise" actually means when a supplement brand uses it in a headline.

Key Takeaways:

• Perimenopause uncertainty — not knowing whether your symptoms are perimenopause or something else — is now recognized in peer-reviewed research as a clinically meaningful phenomenon, distinct from illness-related uncertainty.

• The uncertainty isn't just uncomfortable; it delays validation, delays care, and has real mental health consequences for women in the transition.

• Compassionate Mind Training (CMT), a structured group intervention rooted in self-compassion and emotion regulation, showed feasibility and early signal for reducing anxiety and low mood in a randomized controlled trial — though a fully powered effectiveness trial still needs to happen.

• Elysium's NR-based supplement generated a headline claiming it "shows promise" for menopause symptoms — but the source is NutraIngredients, a trade publication, not a peer-reviewed journal, and no independent trial data was available at time of publishing.

• For mood and anxiety specifically, non-hormonal, evidence-adjacent options like CMT are worth watching — particularly for women who can't or don't want to use HRT.

Sources & References:

• Perimenopause uncertainty prevalence and drivers: a mixed-methods study (https://pubmed.ncbi.nlm.nih.gov/42445976/) - Menopause (NAMS Journal)

• Compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal)

• Elysium's supplement shows promise for menopause symptoms (https://news.google.com/rss/articles/CBMiqwFBVV95cUxOM1FUajFEUktpXzkwSXZReDVkcHVGQ2YwZ1gyVnZjX2ZHMzdkWnVPVjlSQ1p1UXYyMDN4ZnV4S2dHcXhxVUpsOVVnLTZfUDQwZWhiSEFlNUFCdG5XdGp2dzJZRHhQUlZwLXcwdWpVSGhiRG9hS29SLWZvV016emt2VjNkalIwN2xxWVhSSi0yRE51WnFGM0tpUFhoRXJWN05fMVJ5RzlfRnZsVVE) - NutraIngredients.com

Listen with full show notes: https://hotflasher.com/episodes/2026-07-24-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers the systemic gaps in menopause diagnosis and treatment, anchored by Melinda French Gates's account of needing three doctors to identify her perimenopause, new Medscape data showing Medicaid patients are half as likely to receive menopause medications, and a NHANES study linking social disadvantage to earlier reproductive aging.

Key Takeaways:

• Melinda French Gates, with full access to elite medical care, still required three separate doctors before receiving a perimenopause diagnosis — illustrating how common diagnostic failure is in menopause care.

• Medicaid patients are approximately half as likely to receive menopause medications compared to privately insured patients, according to new Medscape reporting.

• A NHANES analysis spanning 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — is associated with a shorter reproductive lifespan.

• Food security, housing status, education level, and income were all identified as significant individual contributors to earlier reproductive aging, suggesting menopause timing is partly shaped by social conditions, not just biology.

• These three data points together describe a system where the women most likely to need support accessing menopause care are also the women most likely to enter menopause earlier and least likely to receive treatment for it.

Sources & References:

• Melinda French Gates on perimenopause: "It took me 3 doctors to really diagnose what I was going through" (https://news.google.com/rss/articles/CBMiigFBVV95cUxNU1pycko4bS14emR3dG9NekRMMnpsblJCdnlUOTM4YlVNdWR0OHRRRzNaZVpzbEQ2TkRaemthTW8xMlBlaXJnd2RlM09Hd3Z2d2RndVI1YkNRMTd0bUZrdHk4LW5zd2lnUFNnOWFOOHA5QUloaFNYRWExZWpnaDBGc21kS1VpNjlfT0E) - CBS News

• Medicaid Patients Half as Likely to Get Menopause Meds (https://news.google.com/rss/articles/CBMipgFBVV95cUxPckRCRGI5ZmM0VUtIeU9uRzhyc2VQOTBtcF9wUGtyZGJWSE40X096c1o2d3pod2Q3ZHVic1JzVDI0aVZYWXNYZWd6bXpHaklEYTNUaWUtLWF5V3pDdFo1dTM0MU1lb1NUYjBDS1l4dHFLdWl5OFBFdG5CZDFaQlJJRzNabHdmWXhqaUw3R09hcmRiUkZBWGJienhEYWRtUWFrQnJWMHZR) - Medscape

• Cumulative social determinants of health and reproductive lifespan among US women: NHANES 1999–2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-07-23-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three new studies published July 21, 2026: one on how women with limited incomes in China understand and practice bone health, one on the under-researched link between sleep apnea and overactive bladder in women, and one on smoking's relationship to breast density and cancer risk in Asian women. Nykki looks at what each one tells us — and what the research is still missing.

Key Takeaways:

• Many women aged 40–65 with limited income in China scored low on bone health *practices* even when awareness was moderate, pointing to a knowledge-to-action gap that isn't unique to any one country.

• Obstructive sleep apnea is significantly underdiagnosed in women, and a 2026 narrative review found a meaningful association between OSA and overactive bladder symptoms — a connection that has been studied almost exclusively in male populations until recently.

• Women with sleep apnea who are waking at night to urinate may be experiencing a physiological chain reaction tied to disrupted breathing, not just an isolated bladder issue.

• The smoking and breast density study found that current smokers showed different breast density patterns compared to non-smokers, with implications for mammography sensitivity and cancer risk interpretation in Asian women.

• All three studies share a design limitation worth noting: none of them establish causation, and two are population-specific in ways that limit how far you can generalize the findings.

Sources & References:

• Bone health attitudes and practices in women aged 40–65 with limited income in China (https://pubmed.ncbi.nlm.nih.gov/42480103/) - PubMed

• Obstructive sleep apnea and overactive bladder: expanding the perspective to women (https://pubmed.ncbi.nlm.nih.gov/42479276/) - PubMed

• Smoking habits, breast density changes, and breast cancer risk in Asian women (https://pubmed.ncbi.nlm.nih.gov/42479205/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-07-22-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode goes deep on three underrecognized menopause symptoms: a decade-long review of pain across the transition, new diagnostic criteria for nighttime frequent urination, and a feasibility trial testing compassionate mind training for mood and anxiety. All three studies come from the NAMS journal and were published in July 2026.

Key Takeaways:

• Menopause-associated pain is not one thing — it spans joint pain, headaches, genitourinary pain, and more, each with different hormonal and psychosocial drivers, and a decade of research still hasn't produced a unified clinical framework for managing it.

• Nighttime frequent urination (nocturnal polyuria) is a legitimate menopause symptom, but current diagnostic thresholds were built without adequately accounting for aging female physiology — a new framework proposes anchoring diagnosis to a nocturnal polyuria index of 28% plus symptom bother, which better reflects menopausal women's actual experience.

• A small randomized feasibility trial found compassionate mind training — a structured group program rooted in self-compassion — was acceptable and feasible for women with menopause-related low mood and anxiety, with promising signals on mental health outcomes, though a fully powered trial is still needed.

• The pain review specifically flags that psychosocial context — stress, sleep disruption, history of depression — amplifies menopause pain, which means treating it as purely hormonal will miss a significant part of what's driving it.

• All three studies are in the same NAMS journal issue, and the collective gap they point to is the same: symptoms that real women are living with don't yet have the clinical infrastructure to be properly diagnosed and treated.

Sources & References:

• Menopause-associated pain: a decade review of patterns, determinants, and research priorities (https://pubmed.ncbi.nlm.nih.gov/42412599/) - Menopause (NAMS Journal)

• Derivation and validation of a symptom-anchored diagnostic criterion for nocturnal polyuria in women (https://pubmed.ncbi.nlm.nih.gov/42413021/) - Menopause (NAMS Journal)

• Group-based compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal)

Listen with full show notes: https://hotflasher.com/episodes/2026-07-21-symptom-spotlight

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three research stories from July 2026: a new meta-analysis confirming resistance training's cardiovascular benefits for postmenopausal women, a large NHANES study linking social disadvantage to earlier menopause onset, and a Nature piece calling out England's Women's Health Strategy for ignoring dental health in 13 million menopausal women. Nykki takes positions on what the evidence actually supports, what the systemic failures look like, and why menopause timing isn't just biology.

Key Takeaways:

• A 2026 systematic review and meta-analysis found resistance training improves cardiovascular health markers in postmenopausal women — adding to a growing body of evidence that lifting is genuinely protective, not just aesthetic.

• A NHANES analysis of US women from 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — was associated with a shorter reproductive lifespan, meaning earlier menopause.

• Food security, housing status, education level, and income-to-poverty ratio were the strongest individual contributors within that social determinants mix.

• A Nature-published commentary found that England's Women's Health Strategy makes no provision for the dental health of menopausal women, despite estrogen loss having well-documented effects on gum tissue, bone density in the jaw, and saliva production.

• Menopause timing is not a purely biological event — where and how you live appears to shape when it happens, which has downstream implications for cardiovascular risk, bone density, and cognitive health.

Sources & References:

• Resistance Training Improves Cardiovascular Health in Postmenopausal Women: Systematic Review and Meta-Analysis (https://pubmed.ncbi.nlm.nih.gov/42470140/) - PubMed

• Cumulative social determinants of health and reproductive lifespan among US women: a NHANES 1999-2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal)

• Women's Health Strategy overlooks 13 million menopausal women's dental health (https://news.google.com/rss/articles/CBMiXkFVX3lxTE00UWsyTnQyV04xbVgycjB5XzFrOHBRMHpfb2MzWHhGSVQ3RlhrZEpWZE1IbzZFMDU2WHFfR2R1ZFlOeFJ4bWlqcUQ0b0h1N0V5aFlmczNiLWo5SEZzZFE?oc=5) - Nature / Google News

Listen with full show notes: https://hotflasher.com/episodes/2026-07-20-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three new studies published this week touching on women's health at midlife and beyond. Nykki looks at how neighborhood-level factors shape cardiovascular risk in midlife women, a major international consensus statement on pregnancy- and lactation-associated osteoporosis, and new longitudinal data on whether calcium supplements actually move the needle when you're already on bone-building medication.

Key Takeaways:

• A new study links neighborhood vulnerability — factors like poverty, lack of green space, and pollution exposure — to worse cardiovascular health in midlife women, independent of individual health behaviors.

• Six international bone health organizations released a joint position statement on pregnancy- and lactation-associated osteoporosis (PLO), a rare but serious condition that is frequently missed or misdiagnosed because clinicians aren't trained to look for it.

• A longitudinal observational study found that among older women already on antiresorptive osteoporosis treatment, additional calcium supplementation did not consistently produce better bone outcomes — dietary calcium intake may matter more than supplements.

• The cardiovascular findings suggest that individual lifestyle advice is not sufficient when the environment itself is working against you — a public health problem that individual behavior change cannot solve.

• For women with a history of pregnancy- or breastfeeding-related bone loss, the new PLO consensus statement is worth bringing to a clinician, as standardized guidance has previously been lacking.

Sources & References:

• Sociodemographic and neighborhood vulnerability linked to cardiovascular health in midlife women (https://pubmed.ncbi.nlm.nih.gov/42464805/) - PubMed

• Pregnancy- and lactation-associated osteoporosis: joint position statement from IAPM, IOF, ECTS, ESCEO, IMS, and EMAS (https://pubmed.ncbi.nlm.nih.gov/42464584/) - PubMed

• Dietary vs. supplemental calcium during antiresorptive osteoporosis treatment in older women (https://pubmed.ncbi.nlm.nih.gov/42463975/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-07-17-listener-story

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

A new study published in the NAMS journal Menopause links premature menopause to significantly higher risk of kidney stone disease across two large datasets, including the UK Biobank. Scotland has approved the first non-hormonal menopause drug, expanding options for women who can't or won't use hormone therapy. And Washington State's governor has signed an executive order requiring workplace support for employees experiencing perimenopause and menopause.

Key Takeaways:

• Women who experienced premature menopause (before age 40) showed a consistently higher risk of kidney stone disease across both UK Biobank and NHANES cohorts, with the association holding up across multiple analytical methods.

• Hormone therapy did not meaningfully modify the kidney stone risk, suggesting the connection may be driven by genetic or metabolic factors rather than estrogen loss alone.

• Scotland has approved a non-hormonal drug for menopause symptoms — significant news for the substantial number of women who cannot use or choose not to use HRT.

• Washington Governor Bob Ferguson signed an executive order directing state agencies to support employees experiencing perimenopause and menopause in the workplace, making Washington one of the more concrete US policy actors on this issue.

• The kidney stone–premature menopause link is a reminder that early menopause has downstream health consequences beyond the cardiovascular and bone density risks that get most of the attention.

Sources & References:

• Premature menopause and risk of kidney stone disease: UK Biobank and NHANES evidence (https://pubmed.ncbi.nlm.nih.gov/42445973/) - Menopause (NAMS Journal)

• First non-hormonal menopause drug approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxOSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c5b09sTmJ3?oc=5) - Medscape via Google News

• Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace (https://news.google.com/rss/articles/CBMixwFBVV95cUxNdkFQMEtfUUp1QVpITmdaR0ljbVFnUWg3MFlYclprbTdfa2RMWjNIOU5aTWRSOFhJYU1TMXFfNnhkNUFjWWhOeHZSM19ER3JKYlEtN1pYbjF2YVdXeXJuR3dLR0dvN1QxVjVzTGFlSXdrMTQyelRXV1ppZUFFSzJybXJfVm82OUZUdWw1cjBIMHY1cEtvOWxHMEIxZmlDT1V0TUVVV1JZM1h5S216amZSQ2djSnlhcGloTHotcHJicDhORkQwSzNJ?oc=5) - Governor Bob Ferguson (.gov) via Google News

Listen with full show notes: https://hotflasher.com/episodes/2026-07-16-influencer-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

A new study used Reddit posts to map menopause symptoms that consistently go undocumented in clinical records — and the gap is significant. Scotland has approved fezolinetant (Veoza), the first non-hormonal drug specifically licensed for menopause symptoms. And a 2026 PubMed study found that air pollution — specifically nitrogen oxide and sulfur dioxide — accelerates bone loss in postmenopausal women, with social determinants shaping who bears the most risk.

Key Takeaways:

• Reddit data revealed a wider range of menopause symptoms than what appears in clinical medical records, suggesting clinical documentation consistently undercaptures what women actually experience.

• Scotland has approved fezolinetant (brand name Veoza), a neurokinin 3 receptor antagonist, as the first non-hormonal prescription option specifically licensed for menopause vasomotor symptoms.

• A 2026 study published in PubMed found that nitrogen oxide and sulfur dioxide exposure is associated with measurable bone damage in postmenopausal women in the United States.

• The air pollution–bone loss connection is shaped by social determinants — women with lower income and less access to resources face disproportionately higher risk from the same pollution levels.

• Bone loss after menopause is not purely hormonal; environmental exposures and social circumstances are factors the standard clinical conversation almost never includes.

Sources & References:

• Reddit exposes menopause symptoms often missing from medical records (https://news.google.com/rss/articles/CBMitwFBVV95cUxOYjV6QmVBTjkzRl95S1NsbTJ5ajlseWltYlExZWlvSDhHTG1iT3dpSmZoWFEtWDJ0N1hGS0d5ODBkTURSOTN0d2JfcmdyMVB3NVBPUmhsX242R3VRZzRrRjBzbDlrZkk2ZjdSaE1JUjdYMGF0LV9FQmdRaFlUY1habHZEZUtnMGtWYTEwUlo1NUtTQm9zLVRkX0lWQzQyWm1kOWIxQ21rb1gxdzhlU21sT2JfQzNwWm8?oc=5) - News-Medical

• First Non-Hormonal Menopause Drug Approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxPSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c1b09sTmJ3?oc=5) - Medscape

• Social determinants of vulnerability to nitrogen oxide- and sulfur dioxide-related bone damage among postmenopausal women in the United States (https://pubmed.ncbi.nlm.nih.gov/42454308/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-07-15-myth-busting

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode digs into a new study linking subclinical cartilage degradation to bone density and trace element levels in women with osteopenia and osteoporosis — and why the "subclinical" part matters most. Nykki also looks at a PubMed review on menopause apps and the gap between what they promise and what the evidence supports, plus a fertility-window study with implications that extend well into perimenopause.

Key Takeaways:

• Cartilage degradation in women with osteopenia and osteoporosis may be measurable before symptoms appear, suggesting bone and joint protection strategies may need to start earlier than most women are told.

• Trace elements — including zinc and selenium — showed associations with cartilage and bone health in postmenopausal women in the Abbood et al. study, though the research is observational and can't establish cause.

• A 2026 PubMed review found menopause apps vary widely in clinical accuracy; some provide useful symptom tracking, but others make claims that outrun the evidence behind them.

• Urine hormone monitoring for fertile window modeling (Bouchard et al.) shows meaningful hormonal variability across the reproductive lifespan — which has direct relevance for perimenopausal women still trying to understand their cycles.

• Symptom-tracking apps are most useful as a conversation starter with a clinician, not as a substitute for one.

Sources & References:

• Menopause apps offer empowerment but pose risks (https://pubmed.ncbi.nlm.nih.gov/42444043/) - PubMed

• Modeling fertile window differences across the reproductive lifespan with urine hormone monitoring (https://pubmed.ncbi.nlm.nih.gov/42443950/) - PubMed

• Subclinical cartilage degradation, bone density, and trace elements in peri- and postmenopausal women with osteopenia and osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42442971/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-07-14-symptom-spotlight

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

This episode covers three new papers published July 2026: a systematic review examining HRT safety across women with common health conditions, a methodological critique of how brain-menopause research gets interpreted, and a head-to-head exercise study testing whether intensity level matters for postmenopausal cardiovascular health. Research credibility is the through-line — all three papers are worth understanding on their own terms, not just their headlines.

Key Takeaways:

• A new 2026 systematic review suggests HRT risk-benefit calculations look different depending on specific comorbidities — cardiovascular disease, diabetes, and osteoporosis each carry distinct considerations, and blanket avoidance is not supported across the board.

• A published response paper challenges how cross-sectional study designs are being used to draw conclusions about menopause and brain health — the limitation is about causality, not about whether the brain-menopause connection is real.

• A 2026 RCT found that higher-intensity aerobic exercise produced meaningfully better improvements in cardiorespiratory fitness and cardiometabolic markers in postmenopausal women compared to lower-intensity protocols.

• Cross-sectional brain imaging studies can tell us which brain features correlate with menopausal status, but they cannot tell us whether menopause caused those features — that distinction matters for how we interpret the research.

• The exercise intensity finding matters practically: moderate-effort walking is not equivalent to vigorous aerobic work when it comes to cardiovascular outcomes in this population.

Sources & References:

• Systematic review: hormone replacement therapy in postmenopausal women with medical co-morbidities (https://pubmed.ncbi.nlm.nih.gov/42439012/) - PubMed

• Response to interpreting cross-sectional comparisons of menopausal status and brain outcomes (https://pubmed.ncbi.nlm.nih.gov/42438864/) - PubMed

• Comparative effects of aerobic exercise intensity on cardiorespiratory fitness and cardiometabolic risk in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42438853/) - PubMed

Listen with full show notes: https://hotflasher.com/episodes/2026-07-13-research-roundup

Have a menopause story to share? We'd love to hear it:

https://hotflasher.com/share

---

Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.